D-3⏰Time's almost up! After this Friday, the submission for Abstracts & Cases closes permanently, and this very last opportunity to present at #TCTAP2026 will not return. Hurry and submit your paper today and stand in the spotlight in Seoul next April! 🔗summit-tctap.com/2026/submissio…
📢COMPLEX PCI 2025 연수평점 인정 안내 #COMPLEXPCI2025 연수평점은 반드시 학회장에 방문하셔서 입장 시간과 퇴장 시간을 모두 바코드 시스템을 통해 승인받으셔야 합니다. 자세한 사항은 학회 홈페이지를 통해 확인해 주시기 바랍니다. 🔗평점 승인 내역 확인하기: complex-pci.com/2025/attend_ac…
📢𝑫𝑬𝑨𝑫𝑳𝑰𝑵𝑬 𝑬𝑿𝑻𝑬𝑵𝑫𝑬𝑫! (+ 1 Week) The submission deadline for #TCTAP2026 Abstracts & Cases has been extended by one week! No further extensions will be granted, so make sure to submit your work by next Friday, November 14. 🔗Go Submit: summit-tctap.com/2026/submissio…
🔥8 DAYS LEFT🔥 until the advance registration closes! Benefit from early-bird savings and keep your inquisitive spirit alive for discovery and innovation at #COMPLEXPCI2025, where non-stop passion drives the field of complex coronary interventions. ❤️🔥complex-pci.com/2025/attend_re…
D-2⏰You have just 48 hours left to be part of #TCTAP2026, where groundbreaking research and inspiring discoveries meet global cardiology experts. Submit your science now and discover why presenting at TCTAP is an opportunity you can't miss! 🔗Submit Now: summit-tctap.com/2026/submissio…
🔴 Contemporary Diagnosis & Treatment of Aortic Regurgitation: A State-of-the-Art Review @JACCJournals #Cardiology #CardioEd #echofirst @ShubhaPawar
#TCT2025: The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - INVEST CTO 🔗pcronline.com/News/Whats-new… @KVM83 and @sof_pap14 provide an in-depth review ✍️of this single arm study presented by @AnjaKsnes in San Francisco.…
🔍What's unfolding at the #COMPLEXPCI2025 Workshop sessions? These bring together leading experts for interactive case reviews, theme-based lectures and discussions designed to provide practical insights. Register now and explore the intriguing agenda. 🔗bit.ly/4gypdxm
TCT 2025 LATE BREAKING CLINICAL TRIALS: One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters & leaders for their innovation, hard work and knowledge sharing. Thank you @TCTConference @TCTMD @crfheart team for a…
-Drug-coated balloons for coronary bifurcation lesions -@FezziSimone et al. explore the role of #DCB as a stent-sparing strategy in bifurcation #PCI, highlighting procedural optimisation, hybrid approaches, and future research needs. eurointervention.pcronline.com/article/drug-c… @Dr_TRissanen…
#TCT2025: STRIVE - intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden ✍️pcronline.com/News/Whats-new… @AsherElad reviews this trial presented by Shamir R. Mehta in San Francisco. #interventionalcardiology
In this first randomized trial of treatment strategies in #MINOCA, a stratified treatment, based on comprehensive diagnostic assessment and aetiology-guided therapy, led to a significant improvement in angina. Read the results of the PROMISE trial just published in #EHJ 👉…
✈️#TCTAP2026 Call for Submissions D-7️⃣ Every breakthrough career begins with a bold move, and yours could take flight at TCTAP. Submit your abstracts & cases by next Friday to unlock infinite possibilities for your next big leap forward! 🔗Submit Now: summit-tctap.com/2026/submissio…
💡Over 60 accepted cases will be presented at #COMPLEXPCI2025. ‘Challenging Case Presentation’ will showcase bold approaches and novel solutions like never before! Experience the inspiring fusion of challenge and ingenuity in interventional cardiology. 🔗bit.ly/4gypdxm
Is there a preferred technology? Comparison of clinical outcomes among palaces DCB, limus DCB, 2nd gen and newer DES and POBA. Presented @crfheart #TCT2025 and published simultaneously @ToshikiKuno @rwyeh @EricSecemskyMD @DLBhattMD ahajrnls.org/4qsWBdu
#TCT2025 Hemodynamic collapse during PCI. Run the scenario and algo in brain so you don’t panic if something catastrophic event happens. #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @MartyBLeon @Drroxmehran…
The most anticipated trial at next #TCT2025 is SELUTION DeNovo. So let’s take a closer look. This study represents an important crossroads for drug-coated balloons (DCBs) in de novo lesions, since—apart from small vessels—the results so far have been far from impressive. Let’s…
🧵1/ 💥 NEW ESC-HFA CONSENSUS (EHJ 2025) Non-amyloid treatments in #ATTRCM — the forgotten side of therapy! From diuretics to SGLT2i, CRT, and TAVR👇 #CardioTwitter #HeartFailure #Cardiology #FOAMed
Despite Class I guideline indications, most patients with severe AR remain untreated. This #JACC review outlines advances in Dx, surgical refinements, & emerging transcatheter options to bridge this gap. jacc.org/doi/10.1016/j.… #TCT2025 #vhdAR @aakriti_15 @ShubhaPawar @mori_md
Live from #TCT2025 🇺🇸: VICTORY - a randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons 🎈 for treatment of calcified and refractory coronary lesions Read this review ✍️ by @mirvatalasnag 🔗…
United States Trends
- 1. Veterans Day 215K posts
- 2. Veterans Day 215K posts
- 3. Luka 70.8K posts
- 4. Nico 114K posts
- 5. Mavs 25.6K posts
- 6. #csm220 3,982 posts
- 7. Gambit 20.7K posts
- 8. Kyrie 6,078 posts
- 9. Dumont 20.4K posts
- 10. Wike 48.8K posts
- 11. Arlington National Cemetery 9,042 posts
- 12. Vets 19.9K posts
- 13. #MFFL 2,065 posts
- 14. Mantis 3,205 posts
- 15. Venom 17K posts
- 16. United States Armed Forces 1,463 posts
- 17. Mavericks 29.6K posts
- 18. Made in China 4,723 posts
- 19. Wanda 21.6K posts
- 20. Anthony Davis 5,344 posts
Something went wrong.
Something went wrong.